drug
Epivir-HBV
Marketedupdated 3mo agoby Prasco LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagInfectious Disease2 co-mentions · 2 sources
- druglamivudine2 co-mentions · 2 sources
- drugabacavir sulfate1 co-mentions · 1 sources
- drugTENOFOVIR DISOPROXIL FUMARATE1 co-mentions · 1 sources
- drug(lamivudine + tenofovir disoproxil fumarate)1 co-mentions · 1 sources
- drugAbacavir Sulfate Aurobindo1 co-mentions · 1 sources
- drug(dolutegravir + lamivudine + tenofovir disoproxil fumarate)1 co-mentions · 1 sources
- company$GSKGSK plc1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying Epivir-HBV
- phase3A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
- phase3Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
- phase2A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- phase3A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
- phase4Efficacy and Safety of Doravirine in the Rapid Initiation
- phase3DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
- phase3Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
- phase4Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that